- Home
- CNTA vs ADNT Comparison
CNTA vs ADNT Comparison
Compare CNTA & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- ADNT
- Stock Information
- Founded
- CNTA 2020
- ADNT 2016
- Country
- CNTA United Kingdom
- ADNT Ireland
- Employees
- CNTA N/A
- ADNT N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- ADNT Auto Parts:O.E.M.
- Sector
- CNTA Health Care
- ADNT Consumer Discretionary
- Exchange
- CNTA Nasdaq
- ADNT Nasdaq
- Market Cap
- CNTA 2.3B
- ADNT 1.5B
- IPO Year
- CNTA 2021
- ADNT N/A
- Fundamental
- Price
- CNTA $17.50
- ADNT $16.76
- Analyst Decision
- CNTA Strong Buy
- ADNT Hold
- Analyst Count
- CNTA 7
- ADNT 9
- Target Price
- CNTA $23.71
- ADNT $23.50
- AVG Volume (30 Days)
- CNTA 581.0K
- ADNT 1.0M
- Earning Date
- CNTA 11-12-2024
- ADNT 02-05-2025
- Dividend Yield
- CNTA N/A
- ADNT N/A
- EPS Growth
- CNTA N/A
- ADNT N/A
- EPS
- CNTA N/A
- ADNT 0.20
- Revenue
- CNTA $6,853,000.00
- ADNT $14,688,000,000.00
- Revenue This Year
- CNTA N/A
- ADNT N/A
- Revenue Next Year
- CNTA N/A
- ADNT $0.91
- P/E Ratio
- CNTA N/A
- ADNT $86.15
- Revenue Growth
- CNTA N/A
- ADNT N/A
- 52 Week Low
- CNTA $6.65
- ADNT $16.43
- 52 Week High
- CNTA $18.97
- ADNT $36.04
- Technical
- Relative Strength Index (RSI)
- CNTA 53.43
- ADNT 31.50
- Support Level
- CNTA $15.45
- ADNT $16.82
- Resistance Level
- CNTA $18.00
- ADNT $17.67
- Average True Range (ATR)
- CNTA 1.14
- ADNT 0.69
- MACD
- CNTA -0.05
- ADNT -0.03
- Stochastic Oscillator
- CNTA 76.78
- ADNT 10.41
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
About ADNT Adient plc
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion.